Case Studies
An NIH study of treatments for high blood pressure, called the ALLHAT trial, shows some of the strengths and limitations of comparative effectiveness research to improve patient care. More...
For Reporters
For journalists and other media professionals
USPSTF
Researcher knows common flaws in CER studies, dangers of result's misuse
Submitted by Tony Coelho on Mon, 03/08/2010 - 22:13 | Posted in:A recent article by Jerome Groopman, M.D, provides some valuable, first-hand insight as to what can go wrong when policy makers “give teeth” to comparative effectiveness research (CER) studies by translating results into “best practices.” Groopman’s understanding of the limitations of CER and the complexities of delivery high quality care to each patient, lead him to caution against blunt application of CER in ways that do not give physicians the ability to deviat
New USPSTF guidelines underscore need for patient-centered CER
Submitted by Tony Coelho on Wed, 12/16/2009 - 06:18 | Posted in:A few days ago, I posted about what I saw as one of the key lessons from the controversy over the new U.S. Preventive Services Task Force’s (USPSTF) mammography guidelines, namely, that expert panels can sometimes come to different conclusions based on the same evidence.
PIPC urges inclusion of Senate CER provision in final reform legislation
Submitted by Tony Coelho on Thu, 12/10/2009 - 17:24 | Posted in:Agree or disagree with the recent changes to mammography guidelines by the U.S. Preventive Services Task Force (USPSTF), one thing is clear – two sets of highly qualified experts can come to very different conclusions when looking at the same evidence. This holds big implications for provisions of health care reform like comparative effectiveness research (CER).
